OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has ...
Bacteria can sneakily evade our best efforts at eradication by developing resistance to various pressures in their ...
This study presents a comprehensive approach for assessing multiple quality attributes of antibody-oligonucleotide conjugates ...
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has ent ...
SAN DIEGO and SEOUL, South Korea, Jan. 13, 2026 /PRNewswire/ -- Rakuten Medical, Inc. and LOTTE Biologics today announced that they have signed a ...
Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.
Bacteria can sneakily evade our best efforts at eradication by developing resistance to various pressures in their ...
In lab experiments, bacteria transferred plasmids with AMR genes in the presence of zinc at reduced or nonexistent rates. Stopping the transfer without killing microbes may help reduce AMR without ...
Vermicomposting earthworms help turn manure into organic fertilizer, representing a potential tool against antibiotic ...
Radiopharmaceuticals are one of the most exciting frontiers in oncology and targeted therapies today. By combining biologically active molecules with radionuclides, radiopharmaceuticals can deliver ...
Unchained Labs, the life sciences company that's all about getting biologics and gene therapy researchers the right tool for ...
Vaxcyte is positioned to disrupt the pneumococcal vaccine market with its engineered VAX-31, overcoming carrier suppression limitations faced by incumbents. PCVX's $2.7B cash position supports an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results